Efficacy of Chemotherapy or Chemo-Anti-Pd-1 Combination After Failed Anti-Pd-1 Therapy for Relapsed and Refractory Hodgkin Lymphoma: A Series From Lysa Centers
American Journal of Hematology - United States
doi 10.1002/ajh.25154
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2018
Authors
Publisher
Wiley